Campylobacter jejuni: Enterocolitis and myopericarditis

Alzand, Becker S. N.; İlhan, Muzaffer; Heesen, Wilfred F.; Meeder, Joan G.

doi:10.1016/j.ijcard.2008.12.101

Cited by 14 publications

(12 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A number of C. jejuni-associated myo(peri)carditis cases have been published since 1980 (213)(214)(215)(216)(217)(218)(219)(220)(221)(222)(223)(224)(225)(226)(227)(228)(229)(230). These reports collectively indicate that patients usually present with symptoms such as thoracic pain, with concomitant electrocardiogram changes as well as increased levels of cardiac enzymes, 3 to 5 days after the onset of gastroenteritis.…”

Section: Cardiovascular Complicationsmentioning

confidence: 99%

Global Epidemiology of Campylobacter Infection

et al. 2015

View full text Add to dashboard Cite

SUMMARY Campylobacter jejuni infection is one of the most widespread infectious diseases of the last century. The incidence and prevalence of campylobacteriosis have increased in both developed and developing countries over the last 10 years. The dramatic increase in North America, Europe, and Australia is alarming, and data from parts of Africa, Asia, and the Middle East indicate that campylobacteriosis is endemic in these areas, especially in children. In addition to C. jejuni , there is increasing recognition of the clinical importance of emerging Campylobacter species, including Campylobacter concisus and Campylobacter ureolyticus . Poultry is a major reservoir and source of transmission of campylobacteriosis to humans. Other risk factors include consumption of animal products and water, contact with animals, and international travel. Strategic implementation of multifaceted biocontrol measures to reduce the transmission of this group of pathogens is paramount for public health. Overall, campylobacteriosis is still one of the most important infectious diseases that is likely to challenge global health in the years to come. This review provides a comprehensive overview of the global epidemiology, transmission, and clinical relevance of Campylobacter infection.

show abstract

Section: Cardiovascular Complicationsmentioning

confidence: 99%

Global Epidemiology of Campylobacter Infection

et al. 2015

View full text Add to dashboard Cite

show abstract

“…Guillian-Barré syndrome (GBS) is a well established immunological process involving molecular mimicry between C. Jejuni polysaccharide and ganglia and maturing few weeks after infection 5,6,10 . In most reported cases of CAM, including ours, the gastrointestinal and cardiac symptoms overlapped, making an immunological etiology similar to GBS unlikely 3,4 . C. Jejuni was identified on the basis of positive stool culture in most cases of CAM 3 , including this case as well.…”

mentioning

confidence: 73%

“…Dear Editor, Campylobacter Jejuni (C. Jejuni) is the most common cause of infectious enterocolitis in the developed world, with an annual incidence as high as 1 in 1000 in the developed world and about 2.5 million cases per year in the United States with male gender predominance (1)(2)(3)(4) . Campylobacter-associated myocarditis (CAM) is a very rare and potentially life-threatening complication of C. Jejuni enterocolitis (CEC).…”

mentioning

confidence: 99%

“…Acute myocarditis results from inflammation of the heart muscle mostly due to a viral infection or idiopathic cause. [1][2][3][4][5] Commonly responsible viruses include adenovirus, coxsackievirus, HCV, HIV, and parvovirus B19 6,7 . CAM is an extremely rare, but significant, complication of CEC with very small number of cases reported 8 .…”

mentioning

confidence: 99%

“…There have been eleven reported incidents of CAM [5][6][7][8][9] and eight cases of C. Jejuni-associated myopericarditis (CAMP) 3,4 . One case of atrial fibrillation was associated with CEC 5 .…”

mentioning

confidence: 99%

See 2 more Smart Citations

A case of Acute Myocarditis from Campylobacter Jejuni Enterocolitis

Kurdi

Khayata

Baldie

et al. 2016

ICFJ

View full text Add to dashboard Cite

Gut, bugs, and brain: Role of commensal bacteria in the control of central nervous system disease

Ochoa‐Repáraz¹,

Mielcarz

Begum-Haque³

et al. 2011

Annals of Neurology

148

101

View full text Add to dashboard Cite

The mammalian gastrointestinal track harbors a highly heterogeneous population of microbial organisms that are essential for the complete development of the immune system. The gut microbes or "microbiota," coupled with host genetics, determine the development of both local microbial populations and the immune system to create a complex balance recently termed the "microbiome." Alterations of the gut microbiome may lead to dysregulation of immune responses both in the gut and in distal effector immune sites such as the central nervous system (CNS). Recent findings in experimental autoimmune encephalomyelitis, an animal model of human multiple sclerosis, suggest that altering certain bacterial populations present in the gut can lead to a proinflammatory condition that may result in the development of autoimmune diseases, in particular human multiple sclerosis. In contrast, other commensal bacteria and their antigenic products, when presented in the correct context, can protect against inflammation within the CNS.

show abstract

Campylobacter jejuni: Enterocolitis and myopericarditis

Cited by 14 publications

References 6 publications

Global Epidemiology of Campylobacter Infection

Global Epidemiology of Campylobacter Infection

A case of Acute Myocarditis from Campylobacter Jejuni Enterocolitis

Gut, bugs, and brain: Role of commensal bacteria in the control of central nervous system disease

Contact Info

Product

Resources

About